Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Orbicular Pharmaceutical Technologies logo — Performance, Excellence - Delivered

Orbicular Pharmaceutical Technologies

Performance, Excellence - Delivered

Founded 2010 India India 197 employees Private Equity Total: $20.00M Health Care, Pharmaceutical

General Information

Company Name Orbicular Pharmaceutical Technologies
Founded Year 2010
Location India India +1
Founders / Decision Makers
Team member
Employees 197
Industries Health Care, Pharmaceutical
Funding Stage Private Equity
Social

Get notified when Orbicular Pharmaceutical Technologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Orbicular Pharmaceutical Technologies

Orbicular Pharmaceutical Technologies is a Specialty Pharmaceutical Company based in Hyderabad, India, founded in 2010. The company focuses on developing niche and complex pharmaceutical dosage forms for licensing to global partners. With a 100,000 sq. ft + state-of-the-art Research facility and a team of 300+ competent scientists, the company specializes in generic pharmaceutical product and 505(b)(2) products with complex chemistry, technological barriers, and limited competition for global markets. Their innovative pipeline includes Complex Injectables, Topicals, Ophthalmics, Parenterals, Nasal Sprays/Inhalations, and Complex Peptide combination products targeting various treatment indications. Orbicular Pharmaceutical Technologies' strength lies in its extensive experience in developing cutting edge solutions, proprietary processes, and technologies to deliver products across multiple delivery platforms, including nano-suspensions, nano-emulsions, liposomes, nanoparticles, and long-acting polymeric injectable suspensions. As a result, they are positioned as a one-stop shop ensuring seamless delivery of highly complex products. Their focus on a product domain that is complex, has entry barriers and is lucrative reflects their outcome driven and value generating organization, creating growth partnerships for global pharma players across the entire spectrum of Complex Generics. In conclusion, Orbicular Pharmaceutical Technologies with its strong emphasis on performance excellence signifies a promising player in the pharmaceutical industry, offering potential investment opportunities for venture capitalists seeking innovative solutions in global pharmaceutical markets. To learn more about Orbicular Pharmaceutical Technologies, visit https://orbicular.co.in or reach out to them at [email protected].

Taxonomy: Specialty Pharmaceutical Company, Research and Development, Complex Dosage Forms, Global Licensing, Hyderabad, India, Product Delivery, Generic Pharmaceuticals, Complex Chemistry, Cutting Edge Solutions, Niche Pharmaceutical Products, Technology-driven Processes, Complex Generics, Global Pharma Partnerships, Drug Delivery Platforms, Innovative Product Pipeline

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round •••••• 1
Investor
31 May 2024

Orbicular Pharmaceutical Technologies Alternatives & Competitors

Orbicular Pharmaceutical Technologies vs
DifGen Pharmaceuticals
DifGen Pharmaceuticals India

Defining Success

114 employees
Manufacturing, Pharmaceutical
Compare Orbicular Pharmaceutical Technologies vs DifGen Pharmaceuticals
Orbicular Pharmaceutical Technologies vs
Aquestive Therapeutics
Aquestive Therapeutics United States

A pharmaceutical company advancing medicines to solve patients’ problems with current standards of c...

Post Ipo Equity
142 employees
Pharmaceutical
Compare Orbicular Pharmaceutical Technologies vs Aquestive Therapeutics
Orbicular Pharmaceutical Technologies vs
Integral Biosystems
Integral Biosystems United States

Pharmaceutical Drug Development, CRO, Ophthalmic Drug Delivery, Injectables, Microspheres, Sustained...

11 employees
Also compare with: Orbicular Pharmaceutical Technologies vs Unicus Pharmaceuticals Unicus Pharmaceuticals

FAQ About Orbicular Pharmaceutical Technologies

Performance, Excellence - Delivered
Orbicular Pharmaceutical Technologies was founded in 2010.
Orbicular Pharmaceutical Technologies is headquartered in India.
Orbicular Pharmaceutical Technologies operates in the following industries: Health Care, Pharmaceutical.
Orbicular Pharmaceutical Technologies has approximately 197 employees.
Orbicular Pharmaceutical Technologies has completed 1 funding round, raising a total of $20.00M. The latest funding stage is Private Equity.
Top alternatives and competitors to Orbicular Pharmaceutical Technologies include DifGen Pharmaceuticals , Aquestive Therapeutics, Integral Biosystems, Unicus Pharmaceuticals, Cure Medical Supplies LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orbicular Pharmaceutical Technologies and DifGen Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Orbicular Pharmaceutical Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy